Terri Voepel-Lewis1, Brian Zikmund-Fisher, Ellen L Smith, Sarah Zyzanski, Alan R Tait. 1. *Department of Anesthesiology-Pediatric Section †Department of Health Behavior and Health Education, School of Public Health ‡Department of Internal Medicine §School of Nursing, University of Michigan, Ann Arbor, MI.
Abstract
OBJECTIVES: Evidence of unrelieved childhood pain, adverse drug events (ADE), and deaths suggest that parents may inadequately respond to pain and opioid-related ADE signals. This study examined parents' recognition and response to pain and ADE signals using both dynamic hypothetical scenarios and real at-home opioid decisions. MATERIALS AND METHODS: A total of 514 parents whose children required prescription opioids after discharge were surveyed. Parents made analgesic decisions for 4 hypothetical scenarios wherein the child's pain level and ADE symptoms were altered. After discharge, parents recorded their child's real pain levels, ADEs, and their analgesic decisions. Mixed-effects logistic regression examined the influence of pain and ADE signals on parents' opioid decisions. RESULTS: Pain intensity had a main effect on parents' hypothetical and real decisions to give opioids (P≤0.001). Nausea/vomiting influenced the decision to give the prescribed opioid dose (β=-1.48 [95% confidence interval (CI): -1.78, -1.19], P<0.001) as did oversedation (β=-1.02 [95% CI: -1.30, -0.75], P<0.001); however, parents were more likely to give the prescribed dose for oversedation than nausea/vomiting (odds ratio (OR) =1.53 [95% CI: 1.14, 2.05], P=0.005). Gastrointestinal effects were more likely to motivate a change in postdischarge opioid administration compared with other ADEs (OR=4.41 [95% CI: 1.91, 10.18], P<0.001), whereas sedation symptoms did not (OR=0.46 [95% CI: 0.21, 1.04], P=0.06). DISCUSSION: Findings demonstrated that many parents failed to withhold a prescribed opioid dose for oversedation, suggesting a lack of awareness regarding this potentially serious ADE. Strategies to improve parents' recognition of oversedation and its potential consequences are warranted to improve opioid safety.
OBJECTIVES: Evidence of unrelieved childhood pain, adverse drug events (ADE), and deaths suggest that parents may inadequately respond to pain and opioid-related ADE signals. This study examined parents' recognition and response to pain and ADE signals using both dynamic hypothetical scenarios and real at-home opioid decisions. MATERIALS AND METHODS: A total of 514 parents whose children required prescription opioids after discharge were surveyed. Parents made analgesic decisions for 4 hypothetical scenarios wherein the child's pain level and ADE symptoms were altered. After discharge, parents recorded their child's real pain levels, ADEs, and their analgesic decisions. Mixed-effects logistic regression examined the influence of pain and ADE signals on parents' opioid decisions. RESULTS:Pain intensity had a main effect on parents' hypothetical and real decisions to give opioids (P≤0.001). Nausea/vomiting influenced the decision to give the prescribed opioid dose (β=-1.48 [95% confidence interval (CI): -1.78, -1.19], P<0.001) as did oversedation (β=-1.02 [95% CI: -1.30, -0.75], P<0.001); however, parents were more likely to give the prescribed dose for oversedation than nausea/vomiting (odds ratio (OR) =1.53 [95% CI: 1.14, 2.05], P=0.005). Gastrointestinal effects were more likely to motivate a change in postdischarge opioid administration compared with other ADEs (OR=4.41 [95% CI: 1.91, 10.18], P<0.001), whereas sedation symptoms did not (OR=0.46 [95% CI: 0.21, 1.04], P=0.06). DISCUSSION: Findings demonstrated that many parents failed to withhold a prescribed opioid dose for oversedation, suggesting a lack of awareness regarding this potentially serious ADE. Strategies to improve parents' recognition of oversedation and its potential consequences are warranted to improve opioid safety.
Authors: Terri Voepel-Lewis; Frances A Farley; John Grant; Alan R Tait; Carol J Boyd; Sean Esteban McCabe; Monica Weber; Calista M Harbagh; Brian J Zikmund-Fisher Journal: Pediatrics Date: 2020-01 Impact factor: 7.124
Authors: Terri Voepel-Lewis; Brian J Zikmund-Fisher; Carol J Boyd; Philip T Veliz; Sean E McCabe; Monica J Weber; Alan R Tait Journal: Clin J Pain Date: 2018-06 Impact factor: 3.442
Authors: Terri Voepel-Lewis; Carol J Boyd; Sean E McCabe; Brian J Zikmund-Fisher; Shobha Malviya; John Grant; Monica Weber; Alan R Tait Journal: J Adolesc Health Date: 2018-11 Impact factor: 5.012
Authors: Terri Voepel-Lewis; Shobha Malviya; John A Grant; Sarah Dwyer; Asif Becher; Jacob H Schwartz; Alan R Tait Journal: Pain Date: 2021-03-01 Impact factor: 7.926
Authors: Lorraine I Kelley-Quon; Matthew G Kirkpatrick; Robert L Ricca; Robert Baird; Calista M Harbaugh; Ashley Brady; Paula Garrett; Hale Wills; Jonathan Argo; Karen A Diefenbach; Marion C W Henry; Juan E Sola; Elaa M Mahdi; Adam B Goldin; Shawn D St Peter; Cynthia D Downard; Kenneth S Azarow; Tracy Shields; Eugene Kim Journal: JAMA Surg Date: 2021-01-01 Impact factor: 14.766